Crossmark

Omega-3 fatty acids effectively mitigate high-sensitivity C-reactive protein (hs-CRP) biomarker of inflammation in acute myocardial infarction patients: a randomized, double-blind, placebo-controlled clinical trial

Crossref DOI link: https://doi.org/10.1007/s00210-024-03330-1

Published Online: 2024-07-29

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahmadi, Mostafa

Askari, Vahid Reza

Shahri, Bahram

Mousavi Noghab, Seyed Mahdiar

Jarahi, Lida

Baradaran Rahimi, Vafa
License Information

Text and Data Mining valid from 2024-07-29

Version of Record valid from 2024-07-29
More Information

Article History

Received: 26 June 2024

Accepted: 24 July 2024

First Online: 29 July 2024

Declarations

:

: According to the Mashhad University of Medical Sciences ethics committee, this investigation is ethically approved (IR.MUMS.MEDICAL.REC.1401.214). A registration number was also assigned to this trial at (code. IRCT20220516054874N5) in 2022–08-17. We obtained and signed written informed consent from all participants. In addition, the study was carried out in accordance with the Declaration of Helsinki.

: The manuscript is approved by all authors for publication.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below